Oragenics, Inc. (OGEN), Wednesday announced that its Board of Directors has approved a 1-for-30 reverse stock split of the company's issued and outstanding shares of common stock, par value $0.001 per share.
As a result, every 30 pre-split shares of common stock outstanding will automatically combine into one new share of common stock without any action on the part of holders, the company added.
Oragenics expects the reverse split to be effective on June 3, 2025.
In the pre-market hours, OGEN is trading at $0.18, down 3.80 percent on the New York Stock Exchange American.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.